02.08.2011 • News • Wacker • Q2 2011 • sales and profits

Wacker Chemie Q2 Profit Rises

Wacker Chemie reported that net income for second quarter reached €142.7 million compared to €135.4 million in the year-ago period, resulting in earnings per share of €2.87 versus €2.71 last year.

Second quarter sales increased 10% to €1.33 billion from €1.20 billion for the same period last year mainly due to the higher sales volumes generated by sustained customer demand.

Looking forward, Wacker expects full-year sales and earnings to rise in 2011. group sales are forecast to top €5 billion. EBITDA for fiscal 2011 is anticipated to exceed last year's figure of €1.19 billion.

 

Company

Wacker Chemie

Hanns-Seidel-Platz 4
81737 Munich
Germany

Company contact







Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Top-Feature